HBM Healthcare Investments
HBM Healthcare Investments AG is a Swiss healthcare investment company financing private and public biopharmaceutical, medical technology, and diagnostic companies globally. The firm invests in late-stage private companies, IPO candidates, and listed healthcare leaders across human medicine, biotechnology, and medical devices. Main revenue drivers consist of realized capital gains upon portfolio company exits and IPOs, share of equity earnings, and investment dividend income. HBM Healthcare Investments serves institutional investors, family offices, and private shareholders seeking exposure to high-growth global healthcare innovation. The company holds a market-leading position in Europe as a premier specialized healthcare venture and private equity investor. Headquartered in Zug, Switzerland, it is listed on the SIX Swiss Exchange.
2 of the funds FundTelligence covers report a position in HBM Healthcare Investments.
- Sector
- Financials
- Country
- Switzerland
- Funds holding it
- 2
Funds holding HBM Healthcare Investments
- Kavaljer Investmentbolagsfond — Kavaljer · 3.8 % (partially disclosed portfolio, October 2026)
- DNB Fund Private Equity — DNB · 3.28 % (full portfolio disclosed, September 2026)